2
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Active not recruiting
1
Sponsor Class
INDUSTRY
3
Study Type
Observational
3
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Breast Neoplasms
2929
Neoplasms
2624
Lung Neoplasms
1366
Colorectal Neoplasms
1328
Prostatic Neoplasms
1214
Carcinoma, Non-Small-Cell Lung
1079
Carcinoma, Hepatocellular
782
Stomach Neoplasms
720
Pancreatic Neoplasms
701
Ovarian Neoplasms
586
Colonic Neoplasms
533
Uterine Cervical Neoplasms
497
Head and Neck Neoplasms
495
Rectal Neoplasms
472
Melanoma
467
Multiple Myeloma
463
Esophageal Neoplasms
422
Neoplasm Metastasis
418
Brain Neoplasms
404
Lymphoma
399
Precursor Cell Lymphoblastic Leukemia-Lymphoma
397
Urinary Bladder Neoplasms
386
Leukemia, Myeloid, Acute
385
Leukemia
339
Carcinoma, Renal Cell
329
Liver Neoplasms
320
Endometrial Neoplasms
319
Hematologic Neoplasms
312
Recurrence
298
Disease
272
Interventions
darolutamide
2
Docetaxel
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Observational
×
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
×
Clear all
NCT07395804
2026-05-26
23146
Bayer
Recruiting
500 enrolled
NCT06661122
2026-05-19
HAYATE
Bayer
Recruiting
100 enrolled
NCT06010914
2026-04-15
DADOX
Bayer
Active not recruiting
100 enrolled